Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 19 |
NetGPI | no | yes: 0, no: 20 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005759 | mitochondrial matrix | 5 | 21 |
GO:0031974 | membrane-enclosed lumen | 2 | 21 |
GO:0043233 | organelle lumen | 3 | 21 |
GO:0070013 | intracellular organelle lumen | 4 | 21 |
GO:0110165 | cellular anatomical entity | 1 | 21 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 186 | 190 | PF00656 | 0.518 |
CLV_NRD_NRD_1 | 129 | 131 | PF00675 | 0.313 |
CLV_NRD_NRD_1 | 192 | 194 | PF00675 | 0.301 |
CLV_NRD_NRD_1 | 250 | 252 | PF00675 | 0.345 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.532 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.534 |
CLV_PCSK_FUR_1 | 130 | 134 | PF00082 | 0.243 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.358 |
CLV_PCSK_KEX2_1 | 180 | 182 | PF00082 | 0.316 |
CLV_PCSK_KEX2_1 | 191 | 193 | PF00082 | 0.320 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.527 |
CLV_PCSK_KEX2_1 | 36 | 38 | PF00082 | 0.533 |
CLV_PCSK_PC1ET2_1 | 132 | 134 | PF00082 | 0.224 |
CLV_PCSK_PC1ET2_1 | 180 | 182 | PF00082 | 0.284 |
CLV_PCSK_PC7_1 | 32 | 38 | PF00082 | 0.626 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.450 |
CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.413 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.545 |
DOC_MAPK_gen_1 | 3 | 11 | PF00069 | 0.636 |
DOC_MAPK_MEF2A_6 | 3 | 11 | PF00069 | 0.446 |
DOC_MAPK_NFAT4_5 | 4 | 12 | PF00069 | 0.445 |
DOC_PP4_FxxP_1 | 57 | 60 | PF00568 | 0.443 |
DOC_USP7_MATH_1 | 163 | 167 | PF00917 | 0.530 |
DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.664 |
DOC_USP7_MATH_1 | 30 | 34 | PF00917 | 0.647 |
DOC_USP7_MATH_1 | 73 | 77 | PF00917 | 0.451 |
LIG_14-3-3_CanoR_1 | 4 | 10 | PF00244 | 0.582 |
LIG_14-3-3_CterR_2 | 251 | 255 | PF00244 | 0.545 |
LIG_BRCT_BRCA1_1 | 75 | 79 | PF00533 | 0.395 |
LIG_eIF4E_1 | 122 | 128 | PF01652 | 0.468 |
LIG_FHA_1 | 24 | 30 | PF00498 | 0.690 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.587 |
LIG_FHA_2 | 142 | 148 | PF00498 | 0.468 |
LIG_FHA_2 | 43 | 49 | PF00498 | 0.431 |
LIG_FHA_2 | 97 | 103 | PF00498 | 0.466 |
LIG_LIR_Apic_2 | 196 | 201 | PF02991 | 0.460 |
LIG_LIR_Apic_2 | 56 | 60 | PF02991 | 0.440 |
LIG_LIR_Gen_1 | 119 | 129 | PF02991 | 0.449 |
LIG_LIR_Gen_1 | 76 | 87 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 119 | 125 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 76 | 82 | PF02991 | 0.490 |
LIG_SH2_CRK | 198 | 202 | PF00017 | 0.474 |
LIG_SH2_GRB2like | 122 | 125 | PF00017 | 0.545 |
LIG_SH2_GRB2like | 243 | 246 | PF00017 | 0.468 |
LIG_SH2_SRC | 50 | 53 | PF00017 | 0.341 |
LIG_SH2_STAP1 | 5 | 9 | PF00017 | 0.616 |
LIG_SH2_STAT5 | 122 | 125 | PF00017 | 0.506 |
LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.437 |
LIG_SH2_STAT5 | 243 | 246 | PF00017 | 0.488 |
LIG_SH2_STAT5 | 5 | 8 | PF00017 | 0.687 |
LIG_SH3_3 | 56 | 62 | PF00018 | 0.425 |
LIG_SUMO_SIM_anti_2 | 147 | 153 | PF11976 | 0.440 |
LIG_TRAF2_1 | 159 | 162 | PF00917 | 0.545 |
LIG_WW_3 | 58 | 62 | PF00397 | 0.347 |
MOD_CK1_1 | 142 | 148 | PF00069 | 0.413 |
MOD_CK2_1 | 22 | 28 | PF00069 | 0.499 |
MOD_CK2_1 | 42 | 48 | PF00069 | 0.426 |
MOD_CK2_1 | 96 | 102 | PF00069 | 0.423 |
MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.304 |
MOD_GlcNHglycan | 186 | 189 | PF01048 | 0.320 |
MOD_GlcNHglycan | 73 | 76 | PF01048 | 0.504 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.567 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.490 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.572 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.477 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.644 |
MOD_NEK2_1 | 183 | 188 | PF00069 | 0.524 |
MOD_NEK2_2 | 42 | 47 | PF00069 | 0.537 |
MOD_PKA_1 | 3 | 9 | PF00069 | 0.581 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.582 |
MOD_PKB_1 | 191 | 199 | PF00069 | 0.403 |
MOD_Plk_1 | 139 | 145 | PF00069 | 0.512 |
MOD_Plk_2-3 | 208 | 214 | PF00069 | 0.468 |
TRG_DiLeu_BaEn_4 | 118 | 124 | PF01217 | 0.545 |
TRG_DiLeu_BaLyEn_6 | 245 | 250 | PF01217 | 0.468 |
TRG_DiLeu_BaLyEn_6 | 59 | 64 | PF01217 | 0.526 |
TRG_ENDOCYTIC_2 | 122 | 125 | PF00928 | 0.484 |
TRG_ER_diArg_1 | 191 | 193 | PF00400 | 0.493 |
TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.543 |
TRG_ER_diArg_1 | 35 | 37 | PF00400 | 0.540 |
TRG_NES_CRM1_1 | 147 | 161 | PF08389 | 0.510 |
TRG_NLS_MonoCore_2 | 129 | 134 | PF00514 | 0.440 |
TRG_NLS_MonoExtC_3 | 130 | 135 | PF00514 | 0.440 |
TRG_NLS_MonoExtN_4 | 130 | 135 | PF00514 | 0.440 |
TRG_Pf-PMV_PEXEL_1 | 39 | 43 | PF00026 | 0.548 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P990 | Leptomonas seymouri | 28% | 100% |
A0A0N1HS24 | Leptomonas seymouri | 67% | 100% |
A0A0S4ITN8 | Bodo saltans | 31% | 100% |
A0A1X0NTH7 | Trypanosomatidae | 65% | 98% |
A0A1X0P207 | Trypanosomatidae | 28% | 100% |
A0A3Q8IBW7 | Leishmania donovani | 27% | 94% |
A0A422NJ89 | Trypanosoma rangeli | 26% | 75% |
A4HCI6 | Leishmania braziliensis | 85% | 100% |
A4HI52 | Leishmania braziliensis | 28% | 85% |
A4I007 | Leishmania infantum | 100% | 100% |
A4I5C8 | Leishmania infantum | 27% | 87% |
C9ZQR0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 100% |
C9ZSQ9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 98% |
C9ZU92 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 22% | 69% |
E9AVY0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
E9B0M6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 99% |
Q4Q7K6 | Leishmania major | 28% | 86% |
Q4QBJ9 | Leishmania major | 93% | 100% |
V5BDB3 | Trypanosoma cruzi | 64% | 98% |